1. Home
  2. LRN vs IMVT Comparison

LRN vs IMVT Comparison

Compare LRN & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stride Inc.

LRN

Stride Inc.

HOLD

Current Price

$66.26

Market Cap

6.3B

Sector

Real Estate

ML Signal

HOLD

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$26.71

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LRN
IMVT
Founded
2000
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.3B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
LRN
IMVT
Price
$66.26
$26.71
Analyst Decision
Buy
Buy
Analyst Count
4
10
Target Price
$113.25
$27.75
AVG Volume (30 Days)
1.3M
1.9M
Earning Date
01-27-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
15.30
N/A
EPS
6.34
N/A
Revenue
$2,475,117,000.00
N/A
Revenue This Year
$5.64
N/A
Revenue Next Year
$5.16
N/A
P/E Ratio
$10.37
N/A
Revenue Growth
17.25
N/A
52 Week Low
$60.62
$12.72
52 Week High
$171.17
$28.00

Technical Indicators

Market Signals
Indicator
LRN
IMVT
Relative Strength Index (RSI) 39.72 66.56
Support Level $61.07 $25.84
Resistance Level $67.75 $27.69
Average True Range (ATR) 2.03 1.39
MACD 2.41 0.26
Stochastic Oscillator 77.00 85.42

Price Performance

Historical Comparison
LRN
IMVT

About LRN Stride Inc.

Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional and Private Pay Schools and Other.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

Share on Social Networks: